FI980853L - Uusi DNA ja menetelmä proteiinin valmistamiseksi käyttäen DNA:ta - Google Patents

Uusi DNA ja menetelmä proteiinin valmistamiseksi käyttäen DNA:ta Download PDF

Info

Publication number
FI980853L
FI980853L FI980853A FI980853A FI980853L FI 980853 L FI980853 L FI 980853L FI 980853 A FI980853 A FI 980853A FI 980853 A FI980853 A FI 980853A FI 980853 L FI980853 L FI 980853L
Authority
FI
Finland
Prior art keywords
dna
making protein
new
new dna
protein
Prior art date
Application number
FI980853A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI980853A7 (fi
FI980853A0 (fi
Inventor
Nobuaki Nakagawa
Hisataka Yasuda
Tomonori Morinaga
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Publication of FI980853A0 publication Critical patent/FI980853A0/fi
Publication of FI980853A7 publication Critical patent/FI980853A7/fi
Publication of FI980853L publication Critical patent/FI980853L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI980853A 1996-08-19 1997-08-19 Uusi DNA ja menetelmä proteiinin valmistamiseksi käyttäen DNA:ta FI980853L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8235928A JPH1057071A (ja) 1996-08-19 1996-08-19 新規ｄｎａ及びそれを用いた蛋白質の製造方法
PCT/JP1997/002859 WO1998007840A1 (fr) 1996-08-19 1997-08-19 Nouveaux adn et procede de production de proteines a l'aide de ces derniers

Publications (3)

Publication Number Publication Date
FI980853A0 FI980853A0 (fi) 1998-04-17
FI980853A7 FI980853A7 (fi) 1998-06-15
FI980853L true FI980853L (fi) 1998-06-15

Family

ID=16993321

Family Applications (1)

Application Number Title Priority Date Filing Date
FI980853A FI980853L (fi) 1996-08-19 1997-08-19 Uusi DNA ja menetelmä proteiinin valmistamiseksi käyttäen DNA:ta

Country Status (12)

Country Link
EP (1) EP0874045A1 (cg-RX-API-DMAC7.html)
JP (1) JPH1057071A (cg-RX-API-DMAC7.html)
KR (1) KR20000064276A (cg-RX-API-DMAC7.html)
CN (1) CN1198776A (cg-RX-API-DMAC7.html)
AU (1) AU718458B2 (cg-RX-API-DMAC7.html)
CA (1) CA2235148A1 (cg-RX-API-DMAC7.html)
FI (1) FI980853L (cg-RX-API-DMAC7.html)
HU (1) HUP0001837A3 (cg-RX-API-DMAC7.html)
NO (1) NO981748L (cg-RX-API-DMAC7.html)
NZ (1) NZ330400A (cg-RX-API-DMAC7.html)
WO (1) WO1998007840A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA977402B (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6919434B1 (en) 1995-02-20 2005-07-19 Sankyo Co., Ltd. Monoclonal antibodies that bind OCIF
IL117175A (en) 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
EP0951551B9 (en) 1996-12-23 2012-12-26 Immunex Corporation Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily
WO1998046644A1 (fr) * 1997-04-15 1998-10-22 Snow Brand Milk Products Co., Ltd. Nouvelle proteine et methode de production associee
NZ500253A (en) 1997-04-16 2002-09-27 Amgen Inc Osteoprotegerin binding proteins and receptors
US6316408B1 (en) 1997-04-16 2001-11-13 Amgen Inc. Methods of use for osetoprotegerin binding protein receptors
JP4268684B2 (ja) 1997-09-24 2009-05-27 第一三共株式会社 骨代謝異常症の診断方法
EP2009025B1 (en) 1998-05-14 2011-07-27 Immunex Corporation Method of inhibiting osteoclast activity
PL347559A1 (en) 1998-10-28 2002-04-08 Snow Brand Milk Products Co Ltd Remedies for bone metabolic errors
AUPQ167599A0 (en) * 1999-07-19 1999-08-12 St. Vincent's Institute Of Medical Research Inhibitor of osteoclast precursor formation
WO2001023562A2 (en) * 1999-09-27 2001-04-05 Eli Lilly And Company Osteoprotegerin regulatory region
WO2002081521A2 (en) 2001-04-03 2002-10-17 Société des Produits Nestlé S.A. Osteoprotegerin in milk
ES2437992T3 (es) 2001-05-25 2014-01-15 Human Genome Sciences, Inc. Anticuerpos que se unen inmunoespecíficamente a los receptores de TRAIL
EP2314316A1 (en) 2002-04-05 2011-04-27 Amgen, Inc Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117175A (en) * 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
US6369027B1 (en) * 1995-12-22 2002-04-09 Amgen Inc. Osteoprotegerin

Also Published As

Publication number Publication date
KR20000064276A (ko) 2000-11-06
NZ330400A (en) 1999-05-28
CA2235148A1 (en) 1998-02-26
FI980853A7 (fi) 1998-06-15
EP0874045A4 (cg-RX-API-DMAC7.html) 1998-11-18
NO981748L (no) 1998-06-18
HUP0001837A3 (en) 2002-09-30
MX9803086A (es) 1998-11-29
NO981748D0 (no) 1998-04-17
FI980853A0 (fi) 1998-04-17
JPH1057071A (ja) 1998-03-03
AU718458B2 (en) 2000-04-13
AU3866197A (en) 1998-05-11
CN1198776A (zh) 1998-11-11
EP0874045A1 (en) 1998-10-28
WO1998007840A1 (fr) 1998-02-26
ZA977402B (en) 1999-02-18
HUP0001837A2 (hu) 2000-09-28

Similar Documents

Publication Publication Date Title
FI974016A0 (fi) Proteiinisideaine ja menetelmä proteiinisideaineen muodostamiseksi
FI973402L (fi) Uusia proteiineja ja menetelmiä proteiinien tuottamiseksi
FI972429A0 (fi) Menetelmä ja laite DNA:n sekvensoimiseksi ja DNA:n identifioimiseksi
DE69530277D1 (de) Verfahren zur auswahl von übertragungsvorzügen
IS8368A (is) Ný aðferð
FI972424A7 (fi) Menetelmä geenien identifioimiseksi
FI970648A7 (fi) Menetelmä nukleiinihappojen jakelemiseksi
IL120337A0 (en) Method for joining DNA fragments
FI980853A7 (fi) Uusi DNA ja menetelmä proteiinin valmistamiseksi käyttäen DNA:ta
GB2293883B (en) Method for measuring protein concentration using a protein biosensor
AU1683795A (en) Method for determining protein tertiary structure
DE69514851D1 (de) Interatomares Messverfahren
FI961879L (fi) Aromatisointimenetelmä
IS5106A (is) Ný aðferð
FI940316L (fi) Menetelmä heraproteiinien fraktioimiseksi
EE03643B1 (et) Meetod ja süsteem sümbolijada vastuvõtmiseks
FI971100L (fi) Menetelmä yhdistelmä-DNA-proteiinien, plasmidien ja modifioitujen solujen tuottamiseksi
FI964657L (fi) Geenitestausmenetelmä
NO960766D0 (no) Nytt protein og fremgangsmåte for fremstilling av dette
FI980945L (fi) Menetelmä proteiinien eristämiseksi ja muuntelemiseksi
FI972055A7 (fi) Syljen analysointimenetelmä
FI982487L (fi) Menetelmä ja järjestelmä V5-liitännän hallitsemiseksi
DE69724736D1 (de) Prozessablaufsteuerung
FI954684A7 (fi) Imidobisfosforihapot, menetelmä niiden valmistamiseksi ja niiden käyttö
FI100322B (fi) Menetelmä kaavinpalkkijärjestelyn käyttöön ja kaavinpalkkijärjestely